Pharmaceuticals
Raising Stops on Eli Lilly as the Charts Weaken
Here's what I recommend.
Is Exact Sciences Ready to Attempt Another Rally?
What are the odds?
How Far Can Vertex Pharmaceuticals Rally?
Let's check the charts for the answer.
AbbVie's Charts Look Strong Ahead of Earnings
Here's the next area for our price target.
Is Moderna's Bumpy Ride Lower Over for Now?
The stock is trading higher Monday on full approval for its Covid vaccine.
This Portfolio of Last Year's Losers Is Up (Surprise!) in a Down Market
The 2022 Tax Loss Selling Recovery Portfolio is holding its own despite difficult market conditions.
An Experienced Hand Launches 3 ETFs Under His Own Flag
ETF veteran Kevin Kelly is the force behind Kelly ETFs, which this month introduced three funds with distinctly different focuses.
Johnson & Johnson May Shed Some Tears in This Bear Market Decline
JNJ has been in a longer-term uptrend but that may not be enough to keep the rally going.
Buy Moderna? A Subscriber Wants to Know
Let's take a look at the charts and indicators.
Fast Track or Slow Track, I Still Believe in Genprex's Long-Term Story
This health biotech has been dealt some tough hands, but is still at the table. Here's my take.